おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Monte Rosa Therapeutics
company
About
Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.
- 51 - 100
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $32.50M
- Industries
- Biotechnology,Medical,Therapeutics
- Founded date
- Jan 1, 2018
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways. Its rational approach in targeting disease-causing proteins for degradation will deliver pioneering therapies for cancer and beyond.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$223.50M
Monte Rosa Therapeutics has raised a total of
$223.50M
in funding over 2 rounds. Their latest funding was raised on
Mar 12, 2021 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 12, 2021 | Series C | $95M | 1 | — | — | Detail |
| Sep 24, 2020 | Series B | $96M | 1 | — | — | Detail |
| May 26, 2020 | Series A | $32.50M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Monte Rosa Therapeutics is funded by 1 investors.
Versant Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Versant Ventures
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
